Imaging agent spots TDP-43 clumps in ALS patients in trial
Original source
Imaging agent spots TDP-43 clumps in ALS patients in trial (opens in a new tab)Compass holds only the headline and link for this source, so the summary below is necessarily brief. Please read the original.
Related topics
An imaging agent spotted TDP-43 clumps in people with amyotrophic lateral sclerosis (ALS) during a trial, according to ALS News Today. The available report does not provide details about the participants, imaging method or results.
Why this matters
This may provide a way to detect TDP-43 clumps in people with ALS, but the available information does not show whether it improves diagnosis, monitoring or treatment. It does not change treatment based on the information provided.
Limitations and context
This is based on a news report, not the underlying research paper. The source metadata does not provide the study size, design, participant details, results, peer-review status or whether the finding was preliminary. Further evidence is needed to determine how reliable and useful the imaging agent is.